New approaches to the treatment of patients with dry age-related macular degeneration and concomitant mild stabilized open-angle glaucoma

Cover Page

Cite item

Full Text

Abstract

Relevance. Dystrophic processes in the retina and different types of glaucoma occupy a significant place among ocular disabling conditions. In the present article, the institution’s experience concerning a new approach to treatment of patients with dry age-related macular degeneration and concomitant mild stabilized open-angle glaucoma.

Aim. To clinically estimate the influence of the biologically active dietary supplement “Proluksa” on main visual functions and on the quality of life in patients with dry age-related macular degeneration and concomitant mild stabilized open-angle glaucoma.

Materials and methods. Into the study, 60 patients were included; they were divided into two groups. Patients of the first group received the biologically active dietary supplement “Proluksa”, 2 capsules once a day during three months, and instilled IOP-lowering drops; patients of the second group did not take the biologically active dietary supplement “Proluksa”, they instilled IOP-lowering drops only. Both groups were followed during six months. Three times a standard ophthalmologic examination and instrumental investigations (macular electroretinography, vacuum-compression test with control of visual evoked cortical potentials using a “suction cup”, HRT III of the optic disc, OCT of the macular area) were performed in both groups.

Results. There was a statistically significant positive visual acuity dynamics at stable optimal correction for distance in the group 1; the percentage of relative scotomata decreased in the group 1; vacuum-compression test gave negative results at Visits 1, 2, and 3; the p-100 wave amplitude increased – in the group 1 on the background the biologically active dietary supplement “Proluksa” intake; the a-wave amplitude of the macular ERG increased; according to OCT results, there were no reliable changes in the central retinal area; the optic disc neuroretinal rim width at HRT III remained stable during the whole follow-up period.

Conclusions. According to performed investigations, there were: statistically reliable visual acuity increase at stable optimal correction, statistically significant positive dynamics in retinal photosensitivity, and increase in functional activity of external and internal retinal layers in the macular area. To the third month of preparation intake, patients from the group 1 taking the biologically active dietary supplement “Proluksa” noted the enhancement of image resolution, decrease in visual “defocusing”, better color perception.

About the authors

Vitaly O. Sokolov

Diagnostic Centre No. 7 (Ophthalmological) for Adults and Children

Author for correspondence.
Email: tavros@mail.ru

MD, PhD, Head of the Centre

Russian Federation, Saint Petersburg

Natalya V. Morozova

Diagnostic Centre No. 7 (Ophthalmological) for Adults and Children

Email: tavros@mail.ru

MD, PhD, Deputy Head of the Centre

Russian Federation, Saint Petersburg

Svetlana S. Florentseva

Diagnostic Centre No. 7 (Ophthalmological) for Adults and Children

Email: florochka1970@mail.ru

MD, PhD, Day Hospital Ophthalmologist

Russian Federation, Saint Petersburg

Anton V. Veselov

Diagnostic Centre No. 7 (Ophthalmological) for Adults and Children

Email: v.a.v83@mail.ru

MD, Special Evaluation Methods Departments, Ophthalmologist

Russian Federation, Saint Petersburg

Michail A. Morozov

I.P. Pavlov State Medical University of St. Petersburg

Email: qwertfix@mail.ru

Postgraduate, Department of Ophthalmology

Russian Federation, Saint Petersburg

References

  1. Age-related Macular Degeneration. Ed. by F.G. Holz, D. Pauleikhoff, R.F. Spaide, A.C. Bird. Berlin, Heidelberg: Springer-Verlag; 2013. doi: 10.1007/978-3-642-22107-1.
  2. Нестеров А.П. Первичная открытоугольная глаукома: патогенез и принципы лечения // РМЖ. Клиническая офтальмология. - 2000. - Т. 1. - № 1. - С. 4-5. [Nesterov AP. Pervichnaya otkrytougol’naya glaukoma: patogenez i printsipy lecheniya. RMZh. Klinicheskaya oftal’mologiya. 2000;1(1):4-5. (In Russ.)]
  3. Соколов В.О., Морозова Н.В., Флоренцева С.С., и др. Опыт применения витаминно-минерального комплекса у пациентов с сухой формой возрастной макулодистрофии // РМЖ. Клиническая офтальмология. - 2016. - Т. 16. - № 4. - С. 211-214. [Sokolov VO, Morozova NV, Florentseva SS. Experience with vitamin and mineral complex in patients with dry type of age-related macular degeneration. RMZh. Klinicheskaya oftal’mologiya. 2016;16(4):211-214. (In Russ.)]
  4. Лещенко И.А. О системах и правилах определения остроты зрения // Вестник оптометрии. - 2009. - № 3. - C. 54-58. [Leshchenko IA. O sistemakh i pravilakh opredeleniya ostroty zreniya. Vestnik optometrii. 2009;(3):54-58. (In Russ.)]
  5. Морозова Н.В., Астахов Ю.С., Соколов В.О. Вакуум- компрессионная проба с контролем зрительных вызванных корковых потенциалов для оценки стабилизации глаукомы псевдонормального давления // РМЖ. Клиническая офтальмология. - 2002. - Т. 3. - № 2. - С. 56-58. [Morozova NV, Astakhov YS, Sokolov VO. Vakuum- kompressionnaya proba s kontrolem zritel’nykh vyzvannykh korkovykh potentsialov dlya otsenki stabilizatsii glaukomy psevdonormal’nogo davleniya. RMZh. Klinicheskaya oftal’mologiya. 2002;3(2):56-58. (In Russ.)]
  6. Шамшинова А.М., Волков В.В. Функциональные методы исследования в офтальмологии. - М., 1998. [Shamshinova AM, Volkov VV. Funktsional’nye metody issledovaniya v oftal’mologii. Moscow; 1998. (In Russ.)]
  7. Шамшинова А.М. Зрительные вызванные потенциалы. Опыт применения вызванных потенциалов в клинической практике. - М., 2001. [Shamshinova AM. Zritel’nye vyzvannye potentsialy. Opyt primeneniya vyzvannykh potentsialov v klinicheskoy praktike. Moscow; 2001. (In Russ.)]
  8. Weinreb RN, Liebman J. Медикаментозное лечение глаукомы. 7-й Консенсус Всемирной глаукомной ассоциации. - СПб.: Н-Л, 2014. [Weinreb RN, Liebman J. Medikamentoznoe lechenie glaukomy. 7-y Konsensus Vsemirnoy glaukomnoy assotsiatsii. Saint Petersburg: N-L; 2014. (In Russ.)]

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Visual acuity dynamics in followed groups before the biologically active dietary supplement “Proluksa” intake, in 3 months, and after the intake course (in 6 months) at stable optimal correction for distance in the group 1 (p < 0.05; n = 60)

Download (29KB)
3. Fig. 2. Diagram of the percentage of relative scotomata before and during the biologically active dietary supplement “Proluksa” intake in groups 1 and 2 (p < 0.05; n = 60)

Download (69KB)
4. Fig. 3. Dynamics of the visual evoked cortical potentials p-100 wave amplitude (mcV) in groups 1 and 2 during the whole follow-up period (p < 0.05; n = 60)

Download (70KB)
5. Fig. 4. Dynamics of the visual evoked cortical potentials p-100 wave latency (ms) in groups 1 and 2 during the whole follow-up period (p < 0.05; n = 60)

Download (73KB)
6. Fig. 5. Dynamics of the a-wave amplitude (mcV) of the macular ERG in groups 1 and 2 during the follow-up period (p < 0.05; n = 60)

Download (69KB)
7. Fig. 6. Visual Function Questionnaire-25 (VFQ-25) developed by the National Eye Institute, version 2000, in the group 1

Download (22KB)

Copyright (c) 2018 Sokolov V.O., Morozova N.V., Florentseva S.S., Veselov A.V., Morozov M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies